**Creams for Post-Sclerotherapy Pigmentation: What Actually Works? (Evidence Review)**

Do topical creams actually get rid of brown staining after microsclerotherapy for leg spider veins? In Part 1 of this two-part series, Dr. Haroun Gajraj reviews the scientific evidence behind popular depigmenting treatments for post-sclerotherapy pigmentation (PSP). Discover the crucial difference between hemosiderin and post-inflammatory melanin, why most conventional creams fail to remove iron staining, and what the clinical literature really says about Triple Combination Cream, Thiamidol, Angiogel, and off-label Deferoxamine mesylate. --- 🎓 ADVANCE YOUR CLINICAL PRACTICE *Explore Hands-On Microsclerotherapy Courses:* Elevate your technique and learn how to manage complications with confidence: [https://www.veincare.academy/hands-on...] *Read the Full Review Article & References:* Read our complete evidence review paper and access all clinical citations on our blog: *https://www.veincare.academy/blog/pos... --- ⏱️ VIDEO TIMESTAMPS *00:00* - The Problem: Brown Staining After Microsclerotherapy *00:53* - Do Pigmentation Creams Really Work? (Evidence Overview) *01:56* - Hemosiderin vs. Melanin: The 2 Causes of Post-Sclerotherapy Staining *03:28* - How to Choose the Right Treatment Based on Pigment Type *04:12* - Triple Combination Cream (Kligman’s Formula) & Hydroquinone *05:54* - Azelaic Acid, Kojic Acid, Retinoids & Vitamin C *07:08* - Thiamidol & Angiogel: What Does the Evidence Say? *08:31* - Deferoxamine Mesylate for Hemosiderin Staining (Off-Label Analysis) *10:28* - Deferoxamine Safety Warnings & Side Effects *11:08* - Summary: Key Takeaways for Sclerotherapy Practitioners *12:30* - What's Coming in Part 2 (Prevention & Management Algorithm) --- 💡 KEY CLINICAL TAKEAWAYS 1. *Two Main Pigments:* Hemosiderin is present in 100% of post-sclerotherapy pigmentation cases, whereas post-inflammatory dermal melanin occurs only in a subset (often darker Fitzpatrick skin types 3–6). 2. *Mechanism Matters:* Standard depigmenting agents act as tyrosinase inhibitors targeting melanin—they do *not* clear iron-based hemosiderin staining. 3. *Evidence Status:* No topical cream currently has randomized controlled trial (RCT) evidence specific to post-sclerotherapy pigmentation; evidence is extrapolated from general post-inflammatory hyperpigmentation (PIH) research. 4. *Targeted Therapies:* Deferoxamine directly chelates iron, but it is an off-label systemic agent requiring careful patient consent and monitored administration. --- 📢 ABOUT VEINCARE ACADEMY Led by Dr. Haroun Gajraj, the VeinCare Academy provides evidence-based educational resources, practical guides, and hands-on masterclasses for healthcare professionals performing microsclerotherapy and vein treatments. *Subscribe for Part 2:* Next week, we cover prevention strategies and present a complete staged management algorithm for established post-sclerotherapy pigmentation! About the Author Dr Haroun Gajraj is a GMC-registered vein specialist, founder, and Course Director of VeinCare Academy. He is a co-founder and board member of the British Association of Sclerotherapists, and co-author of "Pigmentation after microsclerotherapy: causes, prevention and management" in the Journal of Sclerotherapy. Disclaimer: This educational article is intended for qualified healthcare professionals. It serves general educational purposes only and does not replace clinical judgment, individual patient assessment, or local regulatory protocols. #Microsclerotherapy #Sclerotherapy #SpiderVeins #VeinTreatment #Phlebology #MedicalEducation #VeinCareAcademy